Search results
Author(s):
Ferdinando Iellamo
,
Karl Werdan
,
Krzysztof Narkiewicz
,
et al
Added:
3 years ago
Cardiovascular disease (CVD) is the leading cause of death worldwide and it is predicted that its incidence will increase markedly, particularly in developed countries, despite the introduction of new drugs and devices. One of the factors accounting for the limited effectiveness of pharmacological therapy is poor adherence to treatment, particularly in elderly patients. The use of combinations of…
View more
Author(s):
Marco Metra
,
Elisabetta Dinatolo
,
Nicolò Dasseni
Added:
3 years ago
Despite improvements in treatment, heart failure (HF) continues to have a progressive clinical course characterised by worsening of cardiac function and clinical condition, leading to a stage of advanced chronic HF. At this stage, the clinical picture is characterised by severe symptoms, frequent episodes of decompensation, poor quality of life and poor survival. Evidence-based medical treatments…
View more
Author(s):
Patrik Bachtiger
,
Carla M Plymen
,
Punam A Pabari
,
et al
Added:
3 years ago
Although cardiovascular disease is the leading cause of death globally, an increasing proportion of patients are surviving with heart failure (HF), which is substantially increasing in incidence and prevalence.1,2 In the management of HF the indications for implanted devices have widened, resulting in more patients living with an expanding variety of sensor-enabled implanted devices than any…
View more
Author(s):
Georg Nickenig
,
Jur ten Berg
Added:
5 years ago
Author(s):
Michala Sejr
Added:
5 years ago
Dr Michala Sejr (Institut for Klinisk Medicin, Herning, DK) discusses comparison of simultaneous two-day external loop recording and Holter monitor recording for detection of atrial fibrillation in patients after acute ischemic stroke or transient ischemic attack
Filmed by Radcliffe Cardiology on-site at ESC 2018
View more
John Paisey
Research Area(s) / Expertise:
Job title: Consultant Cardiac Electrophysiologist
Author
Author(s):
Martha Gulati
Added:
1 year ago
ESC Congress 2022 — In this short and practice-focused review, Dr Martha Gulati, Associate Director of the Barbra Streisand Women Heart Center and Director of CVD Prevention(Cedars-Sinai Medical Center, US) shares some her thoughts on the top 3 hot line trials.
Trials covered in detail include:
00:27: TIME:The Treatment in Morning versus Evening
01:57: SECURE:A polypill strategy in secondary…
View more
Foreword
Author(s):
Andrew JS Coats
,
Giuseppe Rosano
Added:
3 years ago
Article
Author(s):
Gassan Moady
,
Shaul Atar
,
Binyamin Ben-Avraham
,
et al
Added:
1 year ago
Author(s):
Sebastiaan HC Klaassen
,
Dirk J van Veldhuisen
,
Hans LA Nienhuis
,
et al
Added:
3 years ago
Heart failure with a preserved ejection fraction (HFpEF) comprises half of the heart failure population, and is associated with high morbidity and mortality. HFpEF is induced by multiple coexisting comorbidities, mostly of non-cardiac origin, leading to increased stiffness of the myocardial wall, diastolic dysfunction, elevated filling pressures and eventually to heart failure.1 The interplay…
View more